DNAJC3-AS1 Is Associated with Proliferation, Metastasis, and Poor Prognosis of Breast Cancer

Table 2

Multivariate survival analysis of overall survival and disease-free survival in 170 BC patients.

Variables	Overall survival			Disease-free survival
	RR	95% CI		RR	95% CI
Age	0.895	0.472-1.665	0.217	0.938	0.623-1.894	0.185
Tumor size	1.217	0.774-2.184	0.137	1.443	0.582-2.331	0.118
Differentiation grade	1.341	0.675-2.211	0.176	0.986	0.776-1.978	0.328
Histological type	1.544	0.784-2.019	0.132	1.492	0.998-1.987	0.247
ER status	0.897	0.472-1.896	0.337	1.127	0.632-2.018	0.132
PR status	1.137	0.663-2.123	0.216	1.328	0.853-2.289	0.137
HER-2 status	0.986	0.527-1.897	0.238	1.132	0.773-2.218	0.198
Lymph node metastasis	3.254	1.327-6.237	0.001	3.582	1.498-7.382	0.001
Clinical stage	3.018	1.227-4.786	0.008	3.237	1.426-5.334	0.002
DNAJC3-AS1 expression	2.956	1.285-4.892	0.003	3.228	1.328-5.218	0.001